文献速递胸部技术与安全CT

模拟病灶作为胸部CT容积测量中临床病灶替代物的评估:一项国际挑战赛结果

Evaluation of Simulated Lesions as Surrogates to Clinical Lesions for Thoracic CT Volumetry: The Results of an International Challenge.
PubMed 文献 · Acad Radiol · 2018-09-12

该国际挑战赛利用含16个物理病灶的体模和30例病理确诊恶性肿瘤患者数据,通过三种虚拟插入方法生成混合数据集,比较真实与模拟病灶的容积测量偏差、重复性、再现性及QIBA合规性。体模阶段8组中3组完全合规、1组边缘合规;临床阶段16组中7组合规;无虚拟插入方法在偏差等效性检验中与物理插入达到统计学等效,但差异幅度小(<5.4%),模拟病灶可能作为实用替代物。

要点

  • 体模阶段8组中3组完全QIBA合规、1组边缘合规,临床阶段16组中7组合规。
  • 合规组估计偏差为-1.8±1.4%、-2.5±1.1%、-3±1%、-1.8±1.5%(±95%CI)。
  • 无虚拟插入方法在偏差等效性检验中与物理插入达到统计学等效(±5%等效界值)。

核心结论

  • 混合数据集得出的结论与真实CT数据集相似,体模QIBA合规者混合数据集亦合规。
  • 部分在模拟方法下判定合规的组,在物理病灶测量下不合规,差异幅度小(<5.4%)。
  • 模拟病灶与真实病灶技术性能虽不等效但相关,容积模拟病灶可能作为实用替代物。

研究设计与样本

  • 国际挑战赛研究,使用含16个嵌入物理病灶的人体模和30例来自Reference Image Database to Evaluate Therapy Response的病理确诊恶性肿瘤患者病例。
  • 通过一种投影域方法(方法1)和两种图像域插入方法(方法2和方法3)将对应物理病灶的模拟病灶虚拟插入体模数据集,并用方法2将对应真实病灶的模拟病灶插入临床数据集,生成混合数据集。
  • 比较真实与模拟病灶的容积,基于偏差(体模中物理与虚拟插入病灶经分割算法量化的平均容积差异)、重复性、再现性、等效性(体模阶段)和总体QIBA合规性(体模与临床阶段)。

诊断标准与关键数值

  • 体模阶段8组中3组完全QIBA合规,1组边缘合规;合规组估计偏差为-1.8±1.4%、-2.5±1.1%、-3±1%、-1.8±1.5%(±95%CI)。
  • 采用Schuirmann双侧检验(±5%等效界值)进行偏差等效性检验,无虚拟插入方法与物理插入达到统计学等效。
  • 物理与模拟病灶重复性差异0.1%-16%,再现性差异7%-18%。
  • 临床阶段16组中7组QIBA合规。

临床应用与阅片要点

  • 模拟病灶与真实病灶的容积测量技术性能不等效但相关,容积模拟病灶可能作为实用替代物。
  • 体模QIBA合规的组在混合数据集亦合规,但部分模拟方法合规的组在物理病灶测量下不合规,差异幅度<5.4%。

局限性

  • 无虚拟插入方法在偏差等效性检验中与物理插入达到统计学等效(±5%等效界值)。
  • 部分在模拟方法下判定合规的组在物理病灶测量下不合规,差异幅度<5.4%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate a new approach to establish compliance of segmentation tools with the computed tomography volumetry profile of the Quantitative Imaging Biomarker Alliance (QIBA); and determine the statistical exchangeability between real and simulated lesions through an international challenge.

MATERIALS AND METHODS: The study used an anthropomorphic phantom with 16 embedded physical lesions and 30 patient cases from the Reference Image Database to Evaluate Therapy Response with pathologically confirmed malignancies. Hybrid datasets were generated by virtually inserting simulated lesions corresponding to physical lesions into the phantom datasets using one projection-domain-based method (Method 1), two image-domain insertion methods (Methods 2 and 3), and simulated lesions corresponding to real lesions into the Reference Image Database to Evaluate Therapy Response dataset (using Method 2). The volumes of the real and simulated lesions were compared based on bias (measured mean volume differences between physical and virtually inserted lesions in phantoms as quantified by segmentation algorithms), repeatability, reproducibility, equivalence (phantom phase), and overall QIBA compliance (phantom and clinical phase).

RESULTS: For phantom phase, three of eight groups were fully QIBA compliant, and one was marginally compliant. For compliant groups, the estimated biases were -1.8 ± 1.4%, -2.5 ± 1.1%, -3 ± 1%, -1.8 ± 1.5% (±95% confidence interval). No virtual insertion method showed statistical equivalence to physical insertion in bias equivalence testing using Schuirmann's two one-sided test (±5% equivalence margin). Differences in repeatability and reproducibility across physical and simulated lesions were largely comparable (0.1%-16% and 7%-18% differences, respectively). For clinical phase, 7 of 16 groups were QIBA compliant.

CONCLUSION: Hybrid datasets yielded conclusions similar to real computed tomography datasets where phantom QIBA compliant was also compliant for hybrid datasets. Some groups deemed compliant for simulated methods, not for physical lesion measurements. The magnitude of this difference was small (<5.4%). While technical performance is not equivalent, they correlate, such that, volumetrically simulated lesions could potentially serve as practical proxies.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Robins M, Kalpathy-Cramer J, Obuchowski NA, et al. Evaluation of Simulated Lesions as Surrogates to Clinical Lesions for Thoracic CT Volumetry: The Results of an International Challenge. Acad Radiol. 2018. PMID: 30219290. doi:10.1016/j.acra.2018.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。